Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 90351-90400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04565028
Functional Outcomes of Cannabis Use (FOCUS) in Veterans With Posttraumatic Stress Disorder
NA
Recruiting
40 participants
Started: Jan 26, 2022 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT05171491
LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
N/A
Active, not recruiting
425 participants
Started: Jan 26, 2022 · Completed: Sep 2, 2024
2 conditions
1 sponsor
12 locations
NCT06497829
Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency
NA
Recruiting
6 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05253235
Health and Resilience Projects: Foundations
NA
Recruiting
650 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05450991
Long-term Qualitative and Quantitative Outcomes of Children With Hirschsprung's Disease and Anorectal Malformations
N/A
Recruiting
1,200 participants
Started: Jan 25, 2022 · Completed: Dec 1, 2028
2 conditions
1 sponsor
1 location
NCT05199909
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
PHASE2
Recruiting
10 participants
Started: Jan 25, 2022 · Completed: Jun 30, 2025
3 conditions
1 sponsor
2 locations
NCT05636839
UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3
NA
Recruiting
20 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05681325
Evaluation of Antioxidant and Anti-inflammatory Effect of Matcha Tea Intake on Periodontal Health
NA
Active, not recruiting
40 participants
Started: Jan 25, 2022 · Completed: Jul 12, 2024
1 condition
1 sponsor
1 location
NCT03851627
Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
PHASE4
Recruiting
32 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2028
4 conditions
2 sponsors
1 location
NCT05084638
Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.
PHASE4
Active, not recruiting
180 participants
Started: Jan 25, 2022 · Completed: Feb 16, 2026
1 condition
1 sponsor
36 locations
NCT05161494
Gait in Rare Diseases
N/A
Active, not recruiting
70 participants
Started: Jan 25, 2022 · Completed: Jan 30, 2026
2 conditions
2 sponsors
1 location
NCT05136755
NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
PHASE2
Recruiting
50 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04925544
Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies
PHASE2
Active, not recruiting
13 participants
Started: Jan 25, 2022 · Completed: Jun 17, 2027
2 conditions
3 sponsors
1 location
NCT05273762
Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever
NA
Recruiting
30 participants
Started: Jan 25, 2022 · Completed: Jul 25, 2024
1 condition
2 sponsors
2 locations
NCT04841291
Feasibility of Virtual Simulation-Based Diabetes Foot Care Education in Patients With Diabetes in Ethiopia
NA
Recruiting
40 participants
Started: Jan 25, 2022 · Completed: Dec 15, 2024
1 condition
1 sponsor
1 location
NCT05315206
Multimodal Morpho-functional Study in Glaucoma Patients-Citicoline Oral Solution
NA
Active, not recruiting
29 participants
Started: Jan 25, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
2 locations
NCT05136677
A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants
PHASE2
Active, not recruiting
100 participants
Started: Jan 25, 2022 · Completed: Oct 8, 2026
1 condition
1 sponsor
21 locations
NCT07043413
Thrombus Analysis of Ischemic Stroke
N/A
Recruiting
500 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT04919824
Monopolar Current Cutting Knife vs Bipolar RFA Knife
NA
Active, not recruiting
80 participants
Started: Jan 25, 2022 · Completed: Oct 30, 2025
1 condition
1 sponsor
2 locations
NCT05253846
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29
PHASE2
Active, not recruiting
63 participants
Started: Jan 25, 2022 · Completed: Oct 30, 2028
1 condition
1 sponsor
1 location
NCT04564898
Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.
PHASE1/PHASE2
Active, not recruiting
48 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT04487925
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
PHASE4
Recruiting
208 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT06576050
WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise
N/A
Active, not recruiting
21 participants
Started: Jan 25, 2022 · Completed: Nov 1, 2024
4 conditions
2 sponsors
1 location
NCT05104853
Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects with Primary Biliary Cholangitis
PHASE1/PHASE2
Active, not recruiting
42 participants
Started: Jan 25, 2022 · Completed: Jan 30, 2026
1 condition
1 sponsor
19 locations
NCT05260671
Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN
PHASE2
Recruiting
48 participants
Started: Jan 25, 2022 · Completed: Dec 25, 2026
3 conditions
1 sponsor
2 locations
NCT05098132
STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors
PHASE1
Recruiting
202 participants
Started: Jan 25, 2022 · Completed: Oct 31, 2027
13 conditions
1 sponsor
27 locations
NCT04319146
Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer
NA
Recruiting
20 participants
Started: Jan 25, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT04929392
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
PHASE2
Active, not recruiting
3 participants
Started: Jan 25, 2022 · Completed: Apr 25, 2027
19 conditions
2 sponsors
1 location
NCT05085210
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NA
Recruiting
24 participants
Started: Jan 25, 2022 · Completed: Jun 30, 2026
9 conditions
1 sponsor
1 location
NCT05785364
A Post Market Surveillance Study About the MONOCER Cup
N/A
Recruiting
250 participants
Started: Jan 25, 2022 · Completed: Feb 1, 2050
1 condition
1 sponsor
1 location
NCT05189457
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer
PHASE2
Active, not recruiting
32 participants
Started: Jan 25, 2022 · Completed: Jul 31, 2028
2 conditions
2 sponsors
1 location
NCT05184712
Phase 3 Clinical Study of AK112 for NSCLC Patients
PHASE3
Active, not recruiting
322 participants
Started: Jan 25, 2022 · Completed: Nov 2, 2025
1 condition
1 sponsor
1 location
NCT05088889
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
PHASE1
Recruiting
10 participants
Started: Jan 25, 2022 · Completed: Jul 1, 2024
1 condition
2 sponsors
1 location
NCT05256238
Effect of Exercise in Head and Neck Cancer Patients
NA
Active, not recruiting
150 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05114746
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan
PHASE2
Recruiting
110 participants
Started: Jan 25, 2022 · Completed: Jan 31, 2028
1 condition
2 sponsors
8 locations
NCT05971862
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
36 participants
Started: Jan 25, 2022 · Completed: Oct 4, 2024
1 condition
1 sponsor
3 locations
NCT05195970
Walnuts and Colon Health
NA
Recruiting
200 participants
Started: Jan 24, 2022 · Completed: Dec 31, 2026
2 conditions
8 sponsors
2 locations
NCT05203939
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis
PHASE1/PHASE2
Active, not recruiting
22 participants
Started: Jan 24, 2022 · Completed: Mar 31, 2027
2 conditions
1 sponsor
7 locations
NCT05179447
PROfiling Based Endometrial Cancer Adjuvant Therapy
NA
Recruiting
590 participants
Started: Jan 24, 2022 · Completed: Jan 1, 2027
2 conditions
11 sponsors
10 locations
NCT06299943
Biofeedback Gait Training by Target Biomechanical Parameters in the Early Recovery Period of Stroke
NA
Recruiting
120 participants
Started: Jan 24, 2022 · Completed: Dec 30, 2025
5 conditions
1 sponsor
1 location
NCT04802590
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
PHASE2
Recruiting
194 participants
Started: Jan 24, 2022 · Completed: Sep 30, 2031
1 condition
2 sponsors
45 locations
NCT05887622
The Potassium Supplementation Study
NA
Recruiting
30 participants
Started: Jan 24, 2022 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT05313191
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
NA
Recruiting
1,800 participants
Started: Jan 24, 2022 · Completed: Jan 31, 2027
7 conditions
1 sponsor
1 location
NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
PHASE3
Recruiting
690 participants
Started: Jan 24, 2022 · Completed: Feb 28, 2025
1 condition
1 sponsor
18 locations
NCT06279897
LBNP Tolerance With Skin Warming After Exercise Cold Stress
NA
Active, not recruiting
10 participants
Started: Jan 24, 2022 · Completed: Sep 30, 2026
2 conditions
1 sponsor
1 location
NCT05198154
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
N/A
Recruiting
100 participants
Started: Jan 24, 2022 · Completed: Dec 30, 2025
1 condition
22 sponsors
1 location
NCT04763330
Reducing Suicide Risk in Older Veterans Using Problem Solving Therapy
NA
Recruiting
150 participants
Started: Jan 24, 2022 · Completed: Mar 31, 2026
4 conditions
1 sponsor
2 locations
NCT05260385
To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors
PHASE1/PHASE2
Recruiting
133 participants
Started: Jan 24, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
13 locations
NCT05138575
SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
PHASE2
Recruiting
53 participants
Started: Jan 24, 2022 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT04895956
Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis
PHASE4
Recruiting
80 participants
Started: Jan 24, 2022 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
1805
1806
1807
1808
1809
1810
1811
More pages
2369
Next